-
Product Insights
NewNet Present Value Model: TFF Pharmaceuticals Inc’s Tacrolimus
Empower your strategies with our Net Present Value Model: TFF Pharmaceuticals Inc's Tacrolimus report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AVA-6000 in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AVA-6000 in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AVA-6000 in Pancreatic Ductal Adenocarcinoma Drug Details: AVA-6000 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AVA-6000 in Metastatic Biliary Tract Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AVA-6000 in Metastatic Biliary Tract Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AVA-6000 in Metastatic Biliary Tract Cancer Drug Details: AVA-6000...
-
Product Insights
NewNet Present Value Model: Pfizer Inc’s PF-06480605
Empower your strategies with our Net Present Value Model: Pfizer Inc's PF-06480605 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewEbolavirus Infections (Ebola Hemorrhagic Fever) – Drugs In Development, 2024
Empower your strategies with our Ebolavirus Infections (Ebola Hemorrhagic Fever) – Drugs In Development, 2024 report and make more profitable business decisions. Ebola is a rare but deadly viral infection that causes bleeding inside and outside the body. Signs and symptoms include fever, severe headache, joint and muscle aches, sore throat, nausea and vomiting, diarrhea, chest pain, and cough. Supportive therapy includes oxygen therapy, blood transfusions, intravenous fluids, and pain relievers. The Ebolavirus Infections (Ebola Hemorrhagic Fever) drugs in development market...
-
Product Insights
NewMarburgvirus Infections (Marburg Hemorrhagic Fever) – Drugs In Development, 2024
Empower your strategies with our Marburgvirus Infections (Marburg Hemorrhagic Fever) – Drugs In Development, 2024 report and make more profitable business decisions. Marburg hemorrhagic fever is a rare, acute infectious disease that affects both human and nonhuman primates. Symptoms include fever, headache, chills, weakness, diarrhea, stomach pain, and weight loss. The Marburgvirus Infections (Marburg Hemorrhagic Fever) drugs in development market research report provide comprehensive information on the therapeutics under development for Marburgvirus Infections (Marburg Hemorrhagic Fever), complete with analysis by stage...
-
Product Insights
NewAspergillosis – Drugs In Development, 2024
Empower your strategies with our Aspergillosis – Drugs In Development, 2024 report and make more profitable business decisions. Aspergillosis is an infection or allergic response due to the Aspergillus fungus. Symptoms include cough, fever, headaches, general ill feeling (malaise), weight loss, and chest pain. The predisposing factors include weakened immune system, low white blood cell level, asthma, and long-term corticosteroid therapy. Treatment includes oral corticosteroids, antifungals, and surgery. The Aspergillosis drugs in development market research report provide comprehensive information on the...
-
Product Insights
NewMycoses – Drugs In Development, 2024
Empower your strategies with our Mycoses – Drugs In Development, 2024 report and make more profitable business decisions. Mycoses, also known as fungal infections, encompass a diverse group of diseases caused by fungi. These infections can affect various tissues in the body, including the skin, nails, and internal organs. Superficial mycoses, like athlete's foot and ringworm, involve the outer layers, while systemic mycoses can affect deeper tissues and may be more severe, particularly in individuals with weakened immune systems. Candidiasis is...
-
Product Insights
NewLung Transplant Rejection – Drugs In Development, 2024
Empower your strategies with our Lung Transplant Rejection – Drugs In Development, 2024 report and make more profitable business decisions. Lung transplantation is the therapy used in various lung diseases. A lung transplant replaces an injured or diseased lung with a healthy one. Risk factors associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Following a transplant, the immune system may consider the transplanted lung as foreign and may work against it. Patients may hence develop complications and eventually reject...
-
Product Insights
NewAllergic Bronchopulmonary Aspergillosis – Drugs In Development, 2024
Empower your strategies with our Allergic Bronchopulmonary Aspergillosis – Drugs In Development, 2024 report and make more profitable business decisions. Allergic bronchopulmonary aspergillosis (ABPA) is infection of the lung with Aspergillus fumigatus fungus in those with bronchial asthma, cystic fibrosis, or a compromised immune system. The disease effects are caused by a hypersensitivity reaction to antigens of the Aspergillus species. Clinical manifestations include bronchospasm, pulmonary infiltrates, eosinophilia, and immunologic evidence of allergy to the antigens of Aspergillus species. The Allergic Bronchopulmonary...